|
1
|
Rhee RY and Gloviczki P: Mesenteric venous
thrombosis. Surg Clin North Am. 77:327–338. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brunaud L, Antunes L, Collinet-Adler S,
Marchal F, Ayav A, Bresler L and Boissel P: Acute mesenteric venous
thrombosis: Case for nonoperative management. J Vasc Surg.
34:673–679. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harnik IG and Brandt LJ: Mesenteric venous
thrombosis. Vasc Med. 15:407–418. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Elliot JW: II. The operative relief of
gangrene of intestine due to occlusion of the mesenteric vessels.
Ann Surg. 21:9–23. 1895. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Warren S and Eberhard TP: Mesenteric
venous thrombosis. Surg Gynecol Obstet. 61:102–121. 1935.
|
|
6
|
Zhang J, Duan ZQ, Song QB, Luo YW, Xin SJ
and Zhang Q: Acute mesenteric venous thrombosis: A better outcome
achieved through improved imaging techniques and a changed policy
of clinical management. Eur J Vasc Endovasc Surg. 28:329–334. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jeske WP, Fareed J, Hoppensteadt DA, Lewis
B and Walenga JM: Pharmacology of argatroban. Expert Rev Hematol.
3:527–539. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumar S, Sarr M and Kamath PS: Mesenteric
venous thrombosis. N Engl J Med. 345:1683–1688. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brandt LJ and Boley SJ: AGA technical
review on intestinal ischemia. American Gastrointestinal
Association. Gastroenterology. 118:954–968. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang S, Liu B, Ding W, He C, Wu X and Li
J: Acute superior mesenteric venous thrombosis: Transcatheter
thrombolysis and aspiration thrombectomy therapy by combined route
of superior mesenteric vein and artery in eight patients.
Cardiovasc Intervent Radiol. 38:88–99. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang SF, Liu BC, Ding WW, He CS, Wu XJ and
Li JS: Initial transcatheter thrombolysis for acute superior
mesenteric venous thrombosis. World J Gastroenterol. 20:5483–5492.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hollingshead M, Burke CT, Mauro MA, Weeks
SM, Dixon RG and Jaques PF: Transcatheter thrombolytic therapy for
acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol.
16:651–661. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Swan SK and Hursting MJ: The
pharmacokinetics and pharmacodynamics of argatroban: Effects of
age, gender, and hepatic or renal dysfunction. Pharmacotherapy.
20:318–329. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Berry CN, Girard D, Lochot S and Lecoffre
C: Antithrombotic actions of argatroban in rat models of venous,
‘mixed’ and arterial thrombosis, and its effects on the tail
transection bleeding time. Br J Pharmacol. 113:1209–1214. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hursting MJ, Alford KL, Becker JC, Brooks
RL, Joffrion JL, Knappenberger GD, Kogan PW, Kogan TP, McKinney AA
and Schwarz RP Jr: Novastan (brand of argatroban): A
small-molecule, direct thrombin inhibitor. Semin Thromb Hemost.
23:503–516. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Muta T, Okamura T, Kawamoto M, Ichimiya H,
Yamanaka M, Wada Y, Urata M, Kayamori Y, Hamasaki N, Kato K, et al:
Successful therapy with argatroban for superior mesenteric vein
thrombosis in a patient with congenital antithrombin deficiency.
Eur J Haematol. 75:167–170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dager WE, Gosselin RC and Owings JT:
Argatroban therapy for antithrombin deficiency and mesenteric
thrombosis: Case report and review of the literature.
Pharmacotherapy. 24:659–663. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Young SK, Al-Mondhiry HA, Vaida SJ,
Ambrose A and Botti JJ: Successful use of argatroban during the
third trimester of pregnancy: Case report and review of the
literature. Pharmacotherapy. 28:1531–1536. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Levine RL, Hursting MJ and McCollum D:
Argatroban therapy in heparin-induced thrombocytopenia with hepatic
dysfunction. Chest. 129:1167–1175. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Singal AK, Kamath PS and Tefferi A:
Mesenteric Venous Thrombosis. Mayo Clin Proc. 88:285–294. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schulman S and C; Subcommittee on Control
of Anticoagulation of the Scientific and Standardization Committee
of the International Society on Thrombosis and Haemostasis Kearon:
Definition of major bleeding in clinical investigations of
antihemostatic medicinal products in non-surgical patients. J
Thromb Haemost. 3:692–694. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Doepker B, Mount KL, Ryder LJ, Gerlach AT,
Murphy CV and Philips GS: Bleeding risk factors associated with
argatroban therapy in the critically ill. J Thromb Thrombolysis.
34:491–498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lewis BE, Wallis DE, Berkowitz SD, Matthai
WH, Fareed J, Walenga JM, Bartholomew J, Sham R, Lerner RG, Zeigler
ZR, et al: Argatroban anticoagulant therapy in patients with
heparin-induced thrombocytopenia. Circulation. 103:1838–1843. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Alvi AR, Khan S, Niazi SK, Ghulam M and
Bibi S: Acute mesenteric venous thrombosis: Improved outcome with
early diagnosis and prompt anticoagulation therapy. Int J Surg.
7:210–213. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kearon C, Akl EA, Comerota AJ, Prandoni P,
Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali
F, et al: Antithrombotic therapy for VTE disease: Antithrombotic
Therapy and Prevention of Thrombosis(9th ed). American college of
chest physicians evidence-based clinical practice guidelines.
Chest. 141 2 Suppl:e419S–e496S. 2012.
|
|
26
|
Takahashi N, Kuroki K and Yanaga K:
Percutaneous transhepatic mechanical thrombectomy for acute
mesenteric venous thrombosis. J Endovasc Ther. 12:508–511. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakayama S, Murashima N and Isobe Y:
Superior mesenteric venous thrombosis treated by direct aspiration
thrombectomy. Hepatogastroenterology. 55:367–370. 2008.PubMed/NCBI
|
|
28
|
Poplausky MR, Kaufman JA, Geller SC and
Waltman AC: Mesenteric venous thrombosis treated with urokinase via
the superior mesenteric artery. Gastroenterology. 110:1633–1635.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Riggio O, Ridola L, Lucidi C and Angeloni
S: Emerging issues in the use of transjugular intrahepatic
portosystemic shunt (TIPS) for management of portal hypertension:
Time to update the guidelines? Dig Liver Dis. 42:462–467. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Morasch MD, Ebaugh JL, Chiou AC, Matsumura
JS, Pearce WH and Yao JS: Mesenteric venous thrombosis: A changing
clinical entity. J Vasc Surg. 34:680–684. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Joh JH and Kim DI: Mesenteric and portal
vein thrombosis: Treated with early initiation of anticoagulation.
Eur J Vasc Endovasc Surg. 29:204–208. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Muñoz S, Cubo P, González-Castillo J,
Nuevo JA, García-Lamberechts EJ and Sanz A: Superior mesenteric
venous thrombosis: A retrospective study of thirteen cases. Rev Esp
Enferm Dig. 96:385–394. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cenedese A, Monneuse O, Gruner L, Tissot
E, Mennesson N and Barth X: Initial management of extensive
mesenteric venous thrombosis: Retrospective study of nine cases.
World J Surg. 33:2203–2208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lewis BE, Wallis DE, Leya F, Hursting MJ
and Kelton JG: Argatroban-915 Investigators: Argatroban
anticoagulation in patients with heparin-induced thrombocytopenia.
Arch Intern Med. 163:1849–1856. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rössig L, Genth-Zotz S, Rau M, Heyndrickx
GR, Schneider T, Gulba DC, Desaga M, Buerke M, Harder S and Zeiher
AM: ARG-E04 study group: Argatroban for elective percutaneous
coronary intervention: The ARG-EO4 multi-center study. Int J
Cardiol. 148:214–219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vermeer F, Vahanian A, Fels PW, Besse P,
Müller E, Van de Werf F, Fitzgerald D, Darius H, Puel J, Garrigou
D, et al: Argatroban and alteplase in patients with acute
myocardial infarction: The ARGAMI study. J Thromb Thrombolysis.
10:233–240. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
de Franchis R and V Faculty Baveno:
Revising consensus in portal hypertension: Report of the Baveno V
consensus workshop on methodology of diagnosis and therapy in
portal hypertension. J Hepatol. 53:762–768. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
DeLeve LD, Valla DC and Garcia-Tsao G;
American Association for the Study Liver Diseases: Vascular
disorders of the liver. Hepatology. 49:1729–1764. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Park WS, Kim HI, Jeon BJ, Kim SH and Lee
SO: Should anticoagulants be administered for portal vein
thrombosis associated with acute pancreatitis? World J
Gastroenterol. 18:6168–6171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Beiderlinden M, Treschan TA, Görlinger K
and Peters J: Argatroban anticoagulation in critically ill
patients. Ann Pharmacother. 41:749–754. 2007. View Article : Google Scholar : PubMed/NCBI
|
